Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,461 | 717 | 56.9% |
| Grant | $10,500 | 1 | 30.7% |
| Travel and Lodging | $4,130 | 12 | 12.1% |
| Education | $96.03 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $10,830 | 20 | $0 (2020) |
| Edwards Lifesciences Corporation | $6,848 | 134 | $0 (2024) |
| Abbott Laboratories | $5,743 | 101 | $0 (2024) |
| Boston Scientific Corporation | $1,170 | 23 | $0 (2024) |
| Medtronic, Inc. | $988.46 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $830.85 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $656.43 | 43 | $0 (2024) |
| ShockWave Medical, Inc | $597.13 | 25 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $591.02 | 34 | $0 (2022) |
| PFIZER INC. | $574.29 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,815 | 70 | Edwards Lifesciences Corporation ($685.34) |
| 2023 | $4,202 | 119 | Edwards Lifesciences Corporation ($2,555) |
| 2022 | $5,871 | 108 | Edwards Lifesciences Corporation ($3,060) |
| 2021 | $3,548 | 122 | Abbott Laboratories ($635.93) |
| 2020 | $12,789 | 85 | Medtronic Vascular, Inc. ($10,647) |
| 2019 | $1,342 | 81 | Philips Electronics North America Corporation ($208.86) |
| 2018 | $2,488 | 82 | Abbott Laboratories ($1,610) |
| 2017 | $2,132 | 68 | Abbott Laboratories ($1,362) |
All Payment Transactions
735 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $36.15 | General |
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 11/05/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $17.02 | General |
| 10/29/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $7.00 | General |
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $15.11 | General |
| 10/01/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $7.80 | General |
| 09/25/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 09/17/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $25.73 | General |
| 09/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Not Applicable | ||||||
| 09/11/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $4.23 | General |
| 09/10/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 09/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,471 | 1,580 | $488,048 | $168,924 |
| 2022 | 20 | 1,282 | 1,366 | $424,647 | $156,461 |
| 2021 | 8 | 366 | 377 | $124,535 | $45,886 |
| 2020 | 8 | 525 | 556 | $132,131 | $25,767 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 53 | 53 | $7,420 | $2,968 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $5,120 | $2,545 | 49.7% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 13 | 13 | $6,825 | $2,316 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,575 | $1,644 | 46.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $1,050 | $163.50 | 15.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 167 | 168 | $30,240 | $6,676 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 117 | $31,005 | $6,672 | 21.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 111 | 111 | $32,745 | $5,757 | 17.6% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 15 | 15 | $20,475 | $3,064 | 15.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 21 | 21 | $8,505 | $1,716 | 20.2% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Facility | 2020 | 24 | 35 | $2,336 | $700.62 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 66 | 69 | $5,175 | $669.98 | 12.9% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Facility | 2020 | 18 | 20 | $1,650 | $511.66 | 31.0% |
About Dr. Faisal Saiful, MD
Dr. Faisal Saiful, MD is a Interventional Cardiology healthcare provider based in Klamath Falls, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1205081494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faisal Saiful, MD has received a total of $34,187 in payments from pharmaceutical and medical device companies, with $1,815 received in 2024. These payments were reported across 735 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($19,461).
As a Medicare-enrolled provider, Saiful has provided services to 3,644 Medicare beneficiaries, totaling 3,879 services with total Medicare billing of $397,038. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Klamath Falls, OR
- Active Since 12/01/2008
- Last Updated 10/07/2015
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205081494
Products in Payments
- Asahi Fielder coronary guide wire (Device) $1,192
- Omnilink Elite vascular stent system (Device) $1,181
- MITRACLIP (Device) $1,132
- ELIQUIS (Drug) $692.29
- CoreValve Evolut (Device) $684.80
- WATCHMAN Access System (Device) $601.46
- XARELTO (Drug) $591.02
- BRILINTA (Drug) $579.99
- Vascular Lithotripsy (Device) $574.96
- DIAMONDBACK PERIPHERAL (Device) $567.92
- LifeVest (Device) $554.43
- Xience Sierra Coronary Stent System (Device) $485.61
- Diamondback Coronary (Device) $483.28
- ENTRESTO (Drug) $472.07
- Repatha (Biological) $404.16
- SAPIEN 3 Ultra RESILIA (Device) $336.33
- Impella (Device) $333.91
- Perclose ProGlide suture mediated closure system (Device) $305.67
- JARDIANCE (Drug) $226.33
- FARXIGA (Drug) $218.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.